Effect of age, tumor risk, and comorbidity in a u.s. Population-based cohort of men with prostate cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Scoring Physician Risk Communication in Prostate Cancer Using Large Language Models.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2026
   Article
2. Scoring Physician Risk Communication in Prostate Cancer Using Large Language Models.medRxiv : the preprint server for health sciences · 2025
   Article
3. Use of Persuasive Language in Communication of Risk during Prostate Cancer Treatment Consultations.Medical decision making : an international journal of the Society for Medical Decision Making · 2024
   Article
4. Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy.Prostate cancer and prostatic diseases · 2023
   Article
5. Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer.Prostate cancer and prostatic diseases · 2019
   Article
6. More Judicious Use of Expectant Management for Localized Prostate Cancer during the Last 2 Decades.The Journal of urology · 2017
   Article
7. Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients.Prostate cancer and prostatic diseases · 2015
   Article

Corrections and comments

• Comment on
  Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer.2013
• Comment on
  Effect of age, tumor risk, and comorbidity in a U.S. population-based cohort of men with prostate cancer.2013

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as